First Time Loading...

ATAI Life Sciences NV
NASDAQ:ATAI

Watchlist Manager
ATAI Life Sciences NV Logo
ATAI Life Sciences NV
NASDAQ:ATAI
Watchlist
Price: 1.91 USD -1.55% Market Closed
Updated: May 15, 2024

ATAI Life Sciences NV
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ATAI Life Sciences NV
Operating Income Peer Comparison

Comparables:
BAYN
MRK
93M1
DMP
PSG

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
ATAI Life Sciences NV
NASDAQ:ATAI
Operating Income
-$125.5m
CAGR 3-Years
-11%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bayer AG
XETRA:BAYN
Operating Income
€8.4B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
5%
Merck KGaA
XETRA:MRK
Operating Income
€4.2B
CAGR 3-Years
11%
CAGR 5-Years
15%
CAGR 10-Years
7%
MPH Health Care AG
XETRA:93M1
Operating Income
-€975.1k
CAGR 3-Years
-3%
CAGR 5-Years
3%
CAGR 10-Years
N/A
Dermapharm Holding SE
XETRA:DMP
Operating Income
€201m
CAGR 3-Years
12%
CAGR 5-Years
12%
CAGR 10-Years
N/A
PharmaSGP Holding SE
XETRA:PSG
Operating Income
€17.8m
CAGR 3-Years
-7%
CAGR 5-Years
3%
CAGR 10-Years
N/A

See Also

What is ATAI Life Sciences NV's Operating Income?
Operating Income
-125.5m USD

Based on the financial report for Dec 31, 2023, ATAI Life Sciences NV's Operating Income amounts to -125.5m USD.

What is ATAI Life Sciences NV's Operating Income growth rate?
Operating Income CAGR 3Y
-11%

Over the last year, the Operating Income growth was 13%. The average annual Operating Income growth rates for ATAI Life Sciences NV have been -11% over the past three years .